DF
Definium Therapeutics, Inc. (DFTX)
NASDAQ·Healthcare·Biotechnology
$21.33
+1.67%
Mkt Cap $2.38B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$0.48 | -$0.51 | -5.44% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.52 | -$0.78 | -50.00% | — | — |
| Q3 2025 Jul 31, 2025 | — | — | — | -$0.38 | -$0.50 | -31.58% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.36 | -$0.35 | +2.78% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.33 | -$0.41 | -24.24% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.29 | -$0.27 | +6.90% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.30 | -$0.48 | -60.00% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.66 | -$0.60 | +9.09% | — | — |
| Q1 2024 Feb 28, 2024 | — | $4.84M | — | -$0.48 | -$0.59 | -22.92% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.65 | -$0.53 | +18.46% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.54 | -$0.72 | -33.33% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.41 | -$0.51 | -24.39% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.49 | -$0.27 | +44.90% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.58 | -$0.56 | +3.45% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.75 | -$0.60 | +20.00% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.75 | -$0.60 | +20.00% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$0.70 | -$0.75 | -7.14% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.52 | -$0.90 | -73.08% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.60 | -$1.35 | -125.00% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | — | -$0.57 | — | — | — |